Covid vaccines still cut heart risks: what a large new study shows

It has long been understood that a Covid-19 infection can damage the cardiovascular system. Now a large new study suggests that vaccines may play an even stronger preventive role than previously appreciated.
The research, published this week in JAMA, drew on electronic health records covering millions of patients. Researchers compared the incidence of major cardiovascular events — heart attack, stroke, arrhythmia and myocarditis — between vaccinated and unvaccinated individuals over a multi-year window.
The pattern was striking. Vaccinated patients had a significantly lower risk of major cardiovascular events, with the protective effect visible across both the original mRNA series and the updated variant-matched boosters used in more recent seasons.
The biological logic is consistent with earlier work. Covid itself can inflame heart tissue, trigger microclots and damage blood vessel walls; by reducing infection severity, vaccination short-circuits the cascade that leads to those downstream complications.
Crucially, the authors emphasised that the cardiac protection was not confined to the first waves of the pandemic. Even into the Omicron and post-Omicron era, vaccinated patients carried a lower cardiovascular risk than their unvaccinated peers in the dataset.
Cardiologists who reviewed the findings said the results matter most for older adults and people with pre-existing heart disease. Both groups are far more likely to develop Covid-related cardiac complications, which turns the vaccination decision into a meaningful preventive-medicine choice.
Another important finding speaks directly to one of the most common vaccine concerns. The risk of myocarditis after vaccination is small, usually mild and typically self-resolving, while Covid-induced myocarditis is both more common and more severe — a contrast often missed in public debate.
The authors acknowledge several limits. Because the data are observational, vaccinated and unvaccinated cohorts may differ in lifestyle, socioeconomic factors and healthcare access. But after statistical adjustment, the protective signal remained robust.
Public health officials say studies like this should reframe the conversation around updated Covid vaccines. Most debates focus narrowly on infection prevention, while the cardiovascular dimension — arguably the most consequential long-term effect of Covid — gets less attention.
In the short term, the findings strengthen the rationale for continued annual Covid vaccine recommendations, particularly for higher-risk groups. Vesper presents this information for context only; individual vaccination decisions should be made with medical advice that accounts for personal health history.
Read next

What 'when democracy met science' means at 50: the recombinant DNA story revisited
Fifty years ago, Cambridge, Massachusetts became the first city to publicly debate and regulate recombinant DNA research. As STAT recounts, the story is a reminder of how ordinary citizens can be brought into complex scientific decisions — and offers lessons for today's AI moment.

Nearly 3,000 patients a day on corridor care: inside the NHS's structural crisis
New BBC reporting shows that nearly 3,000 patients a day in England are now receiving care in hospital corridors. Doctors' unions describe the pattern as an 'unacceptable new normal' and are calling for structural fixes.

Reversing prediabetes cuts deadly heart risk by 58%: what the new study shows
New research finds that bringing blood sugar back to normal levels during the prediabetes stage cuts the risk of serious cardiovascular events by 58%. The findings reinforce why prediabetes should be treated as a powerful warning signal, not a minor reading.

One month into DRC's Ebola outbreak: could this be the deadliest yet?
One month into the latest Ebola outbreak in the Democratic Republic of the Congo, health officials warn it could become the deadliest on record if transmission is not contained. Conflict, funding gaps and vaccine logistics are the biggest obstacles to the response.

Calcium and vitamin D for stronger bones: what a major new review actually found
A large new meta-analysis finds that calcium and vitamin D supplements, taken by millions for bone strength, deliver only limited benefit in reducing fracture risk for most healthy adults. The findings suggest the routine reach for these pills may need rethinking.
